The new Embryo Talk podcast is here (#3)
Go listen
The importance of including confounders when building artificial intelligence-based support tools to quantify oocyte viability. By Dr. Cristina Hickman, Chief Clinical Officer, Fairtility
This Israeli-made AI algorithm can help improve the chance of pregnancy in IVF by automatically analyzing embryos.
Researchers can use Fairtility’s AI tool to further their understanding of embryo and oocyte development
Fairtility has developed an AI-based decision support system, which is able to predict an embryo’s viability.
An Israeli startup that uses AI to improve in-vitro fertilization (IVF) cycles has announced a new tool to help women understand the reproductive potential of her oocytes, the cells in her ovaries that may turn into eggs.
Israeli fertility company Fairtility has announced the launch of CHLOE OQ, a tool aimed at fertility preservation, at the 39th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in Copenhagen today.
CHLOE OQ™ secures CE, empowering embryologists and patients with oocyte quality insights for egg freezing, egg donation and IVF applications
The technology is helping clinicians determine the likelihood of an embryo becoming a viable pregnancy
Esco Medical Selects Fairtility’s CHLOE EQ™ as AI Decision Support Tool for MIRI® Time-Lapse Incubators
Israeli-developed artificial intelligence that works to improve in-vitro fertilization (IVF) is now being used across five European countries.
One year following CE MDR clearance, Fairtility has emerged as the AI decision support platform of choice in European fertility practice